Announcements

Classical swine fever, African swine fever, porcine reproductive and respiratory syndrome (PRRS), and other infectious diseases seriously threaten the healthy development of the pig industry. Swine vaccines play a crucial role in preventing and controlling these diseases and can greatly reduce the risk of pigs becoming ill due to viral infection. As the global pig industry pays more and more attention to disease prevention and control, the promotion and rational use of pig vaccines have become key tasks in animal disease prevention and control. This literature list collects recent research results on pig vaccines, covering the evaluation of vaccine immune effects, the response of different pig groups (such as piglets, pregnant sows, etc.) to vaccines, the analysis of the preventive efficacy of vaccines against various swine diseases (such as classical swine fever, African swine fever, swine influenza, etc.), and the optimization of vaccination strategies. This literature list on the topic of pig vaccination may provide you with useful ideas for screening the relevant literature!

1. “Characterization of Glycoprotein 5-Specific Response in Pigs Vaccinated with Modified Live Porcine Reproductive and Respiratory Syndrome Virus Vaccine Derived from Two Different Lineages”
by Jing Huang, Venkatramana D. Krishna, Igor A. D. Paploski, Kimberly VanderWaal, Declan C. Schroeder and Maxim C.-J. Cheeran
Vaccines 2025, 13(3), 247; https://doi.org/10.3390/vaccines13030247
Available online: https://www.mdpi.com/2076-393X/13/3/247

2. “Efficacy of a Self-Vaccination Strategy for Influenza A Virus, Mycoplasma hyopneumoniae, Erysipelothrix rhusiopathiae, and Lawsonia intracellularis in Swine”
by Lucas Caua Spetic da Selva, Rebecca Robbins, Courtney Archer, Madelyn Henderson, Jessica Seate, Luis G. Giménez-Lirola, Ronaldo Magtoto, Arlene Garcia, Allen Jimena Martinez Aguiriano, Emerald Julianna Salinas et al.
Vaccines 2025, 13(3), 229; https://doi.org/10.3390/vaccines13030229
Available online: https://www.mdpi.com/2076-393X/13/3/229

3. “The Pseudotyped Replication-Deficient VSV with Spike from PEDV Induces Neutralizing Antibody Against PEDV”
by Jingxuan Yi, Huaye Luo, Kang Zhang, Lilei Lv, Siqi Li, Yifeng Jiang, Yanjun Zhou, Zuzhang Wei and Changlong Liu
Vaccines 2025, 13(3), 223; https://doi.org/10.3390/vaccines13030223
Available online: https://www.mdpi.com/2076-393X/13/3/223

4. “A Novel Prototype African Swine Fever Virus DIVA (Differentiation Between Infected and Vaccinated Animals) Serological Assay Based on the Detection of Antibodies Against the pEP153R, eGFP, and p72 Proteins”
by Gabriela González-García, Carmina Gallardo, Mercedes Montón, Sandra Barroso-Arévalo, Nadia Casado, José Ángel Barasona, José Manuel Sánchez-Vizcaíno, Ángel Venteo, Patricia Sastre and Paloma Rueda
Vaccines 2025, 13(3), 211; https://doi.org/10.3390/vaccines13030211
Available online: https://www.mdpi.com/2076-393X/13/3/211

5. “A Pool of Bacterium-like Particles Displaying African Swine Fever Virus Antigens Induces Both Humoral and Cellular Immune Responses in Pigs”
by Jingshan Huang, Hongxia Wu, Tianqi Gao, Huanjie Zhai, Assad Moon, Xin Song, Shuwen Li, Zhanhao Lu, Jing Lan, Dailang Zhong et al.
Vaccines 2025, 13(1), 5; https://doi.org/10.3390/vaccines13010005
Available online: https://www.mdpi.com/2076-393X/13/1/5

6. “Double Deletion of EP402R and EP153R in the Attenuated Lv17/WB/Rie1 African Swine Fever Virus (ASFV) Enhances Safety, Provides DIVA Compatibility, and Confers Complete Protection Against a Genotype II Virulent Strain”
by Carmina Gallardo, István Mészáros, Alejandro Soler, Jovita Fernandez-Pinero, Erwin van den Born, Alicia Simón, Nadia Casado, Raquel Nieto, Covadonga Perez, Irene Aldea et al.
Vaccines 2024, 12(12), 1406; https://doi.org/10.3390/vaccines12121406
Available online: https://www.mdpi.com/2076-393X/12/12/1406

7. “Generation and Genetic Stability of a PolX and 5′ MGF-Deficient African Swine Fever Virus Mutant for Vaccine Development”
by Daniel Pérez-Núñez, Daniel W. Madden, Gonzalo Vigara-Astillero, David A. Meekins, Chester D. McDowell, Bianca Libanori-Artiaga, Raquel García-Belmonte, Dashzeveg Bold, Jessie D. Trujillo, Konner Cool et al.
Vaccines 2024, 12(10), 1125; https://doi.org/10.3390/vaccines12101125
Available online: https://www.mdpi.com/2076-393X/12/10/1125

8. “Impact of Oil-in-Water Adjuvanted β-Glucan on Innate Immune Memory in Piglets”
by Razieh Ardali, Obdulio Garcia-Nicolas, Catherine Ollagnier, José María Sánchez Carvajal, Maria Levy, Pauline Yvernault, Francisco de Aboim Borges Fialho de Brito and Artur Summerfield
Vaccines 2024, 12(9), 982; https://doi.org/10.3390/vaccines12090982
Available online: https://www.mdpi.com/2076-393X/12/9/982

9. “Immunogenicity and Protective Efficacy of Dose-Sparing Epigraph Vaccine against H3 Swine Influenza A Virus”
by Erika Petro-Turnquist, Adthakorn Madapong, David Steffen, and Eric A. Weaver
Vaccines 2024, 12(8), 943; https://doi.org/10.3390/vaccines12080943
Available online: https://www.mdpi.com/2076-393X/12/8/943

10. “FlagT4G Vaccine Prevents Transplacental Transmission of Highly Virulent Classical Swine Fever Virus after Single Vaccination in Pregnant Sows”
by Liani Coronado, Adriana Muñoz-Aguilera, Guillermo Cantero, Patricia Martínez, Mònica Alberch, Rosa Rosell, Douglas P. Gladue, Manuel V. Borca and Llilianne Ganges
Vaccines 2024, 12(8), 832; https://doi.org/10.3390/vaccines12080832
Available online: https://www.mdpi.com/2076-393X/12/8/832

11. “Synthetic Peptides Elicit Humoral Response against Porcine Reproductive and Respiratory Syndrome Virus in Swine”
by Francisco Perez-Duran, Fernando Calderon-Rico, Luis Enrique Franco-Correa, Alicia Gabriela Zamora-Aviles, Roberto Ortega-Flores, Daniel Durand-Herrera, Alejandro Bravo-Patiño, Ricarda Cortes-Vieyra, Ilane Hernandez-Morales and Rosa Elvira Nuñez-Anita
Vaccines 2024, 12(6), 652; https://doi.org/10.3390/vaccines12060652
Available online: https://www.mdpi.com/2076-393X/12/6/652

12. “Evaluation of Swine Protection with Three Commercial Foot-and-Mouth Disease Vaccines against Heterologous Challenge with Type A ASIA/G-VII Lineage Viruses”
by Seon Woo Kim, Seung Heon Lee, Ha-Hyun Kim, Sung-Ho Shin, Sang-Hyun Park, Jong-Hyeon Park, Jaejo Kim and Choi-Kyu Park
Vaccines 2024, 12(5), 476; https://doi.org/10.3390/vaccines12050476
Available online: https://www.mdpi.com/2076-393X/12/5/476

13. “Characterization of the Protective Cellular Immune Response in Pigs Immunized Intradermally with the Live Attenuated African Swine Fever Virus (ASFV) Lv17/WB/Rie1”
by Miriam Pedrera, Alejandro Soler, Alicia Simón, Nadia Casado, Covadonga Pérez, María A. García-Casado, Paloma Fernández-Pacheco, Pedro J. Sánchez-Cordón, Marisa Arias and Carmina Gallardo
Vaccines 2024, 12(4), 443; https://doi.org/10.3390/vaccines12040443
Available online: https://www.mdpi.com/2076-393X/12/4/443

14. “A TriAdj-Adjuvanted Chlamydia trachomatis CPAF Protein Vaccine Is Highly Immunogenic in Pigs”
by Jessica Proctor, Maria Stadler, Lizette M. Cortes, David Brodsky, Lydia Poisson, Volker Gerdts, Alex I. Smirnov, Tatyana I. Smirnova, Subarna Barua, Darren Leahy et al.
Vaccines 2024, 12(4), 423; https://doi.org/10.3390/vaccines12040423
Available online: https://www.mdpi.com/2076-393X/12/4/423

15. “Deletion of MGF505-2R Gene Activates the cGAS-STING Pathway Leading to Attenuation and by Protection against Virulent African Swine Fever Virus”
by Sun-Young Sunwoo, Raquel García-Belmonte, Marek Walczak, Gonzalo Vigara-Astillero, Dae-Min Kim, Krzesimir Szymankiewicz, Maciej Kochanowski, Lihong Liu, Dongseob Tark, Katarzyna Podgórska et al.
Vaccines 2024, 12(4), 407; https://doi.org/10.3390/vaccines12040407
Available online: https://www.mdpi.com/2076-393X/12/4/407

MDPI will be attending the 11th Congress of the European Academy of Neurology, which will be held in Helsinki, Finland, from 21 to 24 June 2025. The EAN Congress 2025 is organized by the European Academy of Neurology. Its exciting overarching theme of neurology within society sets the scene for an unforgettable congress and is highly relevant to our practice as neurologists, given our crucial role as clinicians—and in many cases neuroscientists—in addressing the huge burden of neurological disorders. To have an impact, we must work with many other stakeholders and specialties, and we look forward to welcoming many of them to the home of neurology in 2025. As usual, the overarching theme will serve as a common thread throughout all the invited content of our congress, from workshops to plenary sessions.

The following MDPI journals will be represented:

• Brain Sciences;
• JCM;
• CTN;
• Neurology International;
• Neuroglia;
• Cells;
• Diagnostics;
• Neurosci;
• Psychiatry International;
• Antioxidants;
• Biomolecules;
• Genes;
• IJTM;
• Vaccines.

If you plan to attend the conference, please visit our booth #E48. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.ean.org/congress2025.

MDPI journals will be attending the 44th Annual Meeting of the American Society for Virology (ASV 2025) as exhibitors. This meeting will be held in Montréal, Québec, Canada, from 14 to 17 July 2025.

The American Society for Virology’s annual meeting provides a forum with which to promote discussion and collaboration among scientists active in all aspects of virology. Attendees will have the chance to learn about virology, share their research, and network with other scientists.

This conference is hosted by McGill University at the Palais des congrès de Montréal. The annual meeting usually attracts 1500–1800 national and international scientists for a program crafted from over 1000 participant-submitted abstracts, 20 invited symposium speakers, and 6 distinctive state-of-the-art speakers.  

The following MDPI journals will be represented at the conference:

• Viruses;
• Vaccines;
• Pathogens;
• CIMB;
• COVID;
• Life;
• J;
• Biomolecules;
• Aerobiology.

If you are planning to attend this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference and our booth, please visit https://asv.org/asv2025/.

Conference: ASM Microbe 2025
Date: 19–23 Jun 2025
Location: Los Angeles, USA

MDPI will be attending the ASM Microbe 2025 conference as an exhibitor. We welcome researchers from different backgrounds to visit us and share their latest ideas.

Established in 1899, ASM is the home for microbial scientists from around the globe to connect, learn, discover and prepare for the future. ASM and its over 37,000 members partner with global organizations to solve the world’s most pressing challenges. They connect with millions of experts and harness their science to serve humanity. From climate change and antimicrobial resistance to industrial, basic and applied microbiology, ASM is a leader in scientific publishing, stands for open science and advocates for evidence-based public policies.

The organizers have curated groundbreaking scientific sessions on topics that are shaping the future of humanity. From microbial solutions to global problems to artificial intelligence (AI) research, we have something for everyone.

The following is a list of just a few of the cutting-edge topics at the conference:

• Microbes in the wild;
• Early Career research;
• Innovative methods for discovery;
• Microbial chemistry;
• Microbes and human health from a basic science perspective;
• omics.

The following MDPI journals will be represented:

• Microorganisms;
• JoF;
• Fermentation;
• MPs;
• J;
• Microbiology Research;
• Vaccines;
• Biology;
• Bacteria;
• CIMB;
• Antibiotics.

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://asm.org/Events/ASM-Microbe/Home.

We are pleased to announce that the winner of the Vaccines 2024 Young Investigator Award is Dr. Alexandra (Ali) Dvorscek. She completed her Ph.D. in 2024 at Monash University, Australia, under the supervision of Dr. Isaak Quast and Prof. David Tarlinton. Her research focused on investigating the factors that regulate successful antibody production and immune memory formation. Dr. Dvorscek's recent work uncovered a mechanism by which the immune response to vaccination can be substantially enhanced. More specifically, by incorporating small amounts of monoclonal antibodies into vaccines, Alexandra was able to promote the magnitude, duration, and output of the immune response to both protein and mRNA vaccination. These findings can inform future vaccine design and provide insights into how the current vaccine formulations and strategies can be improved. Recently, Dr. Dvorscek relocated to the UK to pursue a postdoctoral position in the lab of Dr. Ryan Thwaites at the Imperial College, where she will investigate the immune response to influenza.

As the awardee, Dr. Alexandra Dvorscek will receive the following honorarium:

• CHF 2000;
• The opportunity to publish one paper free of charge in Vaccines after a peer review (before the end of 2025);
• An electronic certificate.

We would like to thank the award committee for their excellent work in the difficult task of selecting the winner from a pool of excellent candidates, as well as everyone who participated in this award and helped to make it such a success!

Prof. Dr. Ralph A. Tripp
Editor-in-Chief of Vaccines

Conference: 19th Conference of the International Society of Travel Medicine (CISTM19)
Organization: International Society of Travel Medicine
Date: 11–15 May 2025
Place: New Orleans, Louisiana, USA
Booth ID: #19

A number of MDPI journals will be attending CISTM19 as exhibitors. This meeting will be held in New Orleans, USA, from 11 to 15 May 2025.

CISTM19 is the premier gathering of approximately 1,100+ travel medicine specialists and practitioners to learn about the latest developments and new and innovative technologies, products, and services, as well as to contribute to the evolving field of travel medicine.

The following MDPI journals will be represented:

• TropicalMed;
• COVID;
• Diseases;
• Antibiotics;
• Parasitologia;
• Life;
• Viruses;
• Healthcare;
• Vaccines;
• Women;
• Children;
• Infectious Disease Reports;
• Microorganisms;
• Epidemiologia.

If you will be attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.istm.org/event/cistm19/.

MDPI is pleased to share a significant milestone in its mission to advance scholarly research and promote the dissemination of knowledge—300+ MDPI journals are now indexed in Web of Science (WoS). This milestone highlights the global recognition, interdisciplinary impact and enhanced visibility of our journals. It also reflects our adherence to rigorous editorial standards, scientific integrity, and our mission to foster open scientific exchange in all forms, across all disciplines. 

To explore the full list of our journals indexed in WoS, please visit https://www.mdpi.com/about/journals/wos. Beyond expanding the coverage of our publications in the leading academic databases, we are dedicated to ensuring that our journals are included in as many scope-specific databases as possible. This increases the visibility of our authors’ work and extends the reach of their significant data. 

This milestone would not have been possible without the efforts and expertise of our academic editors, reviewers and authors. Their commitment and collaboration have been instrumental in creating an inclusive, accessible, and impactful publishing platform. We also extend our gratitude to the global research community for their trust as we continue to break new ground in academic publishing. This milestone is not just a celebration of MDPI’s progress but also recognition of the collective strides made by researchers worldwide. 

As we celebrate this remarkable accomplishment, MDPI remains steadfast in its commitment to open access publishing and ensuring that high-quality research reaches and inspires a global audience.

We are pleased to present the highly viewed and/or cited papers published by Vaccines (ISSN: 2076-393X) in 2024 on the topic of COVID-19 Vaccines and Vaccination. We would like to take this opportunity to acknowledge the exceptional individuals and teams whose work serves as an inspiration to fellow researchers and significantly impacts the field of COVID-19 vaccine-related research. We are grateful to the journal’s Section Editor-in-Chief, Prof. Dr. Luis Martinez-Sobrido, for his valuable assistance in selecting these papers. We invite you to explore the remarkable works listed below.

1. “Comparative Analysis of Vaccine-Induced Neutralizing Antibodies against the Alpha, Beta, Delta, and Omicron Variants of SARS-CoV-2”
by Philipp Girl, Heiner von Buttlar, Enrico Mantel, Markus H. Antwerpen, Roman Wölfel and Katharina Müller
Vaccines 2024, 12(5), 515; https://doi.org/10.3390/vaccines12050515
Available online: https://www.mdpi.com/2076-393X/12/5/515

2. “Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques”
by Bryce M. Warner, Mable Chan, Nikesh Tailor, Robert Vendramelli, Jonathan Audet, Courtney Meilleur, Thang Truong, Lauren Garnett, Marnie Willman, Geoff Soule et al.
Vaccines 2024, 12(4), 404; https://doi.org/10.3390/vaccines12040404
Available online: https://www.mdpi.com/2076-393X/12/4/404

3. “Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19”
by Nina Ekström, Tuija M. Leino, Aapo Juutinen, Toni Lehtonen, Anu Haveri, Oona Liedes, Saimi Vara, Heini Salo, Arto A. Palmu, Hanna Nohynek et al.
Vaccines 2024, 12(3), 247; https://doi.org/10.3390/vaccines12030247
Available online: https://www.mdpi.com/2076-393X/12/3/247

4. “Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024)”
by Matteo Riccò, Antonio Cascio, Silvia Corrado, Marco Bottazzoli, Federico Marchesi, Renata Gili, Pasquale Gianluca Giuri, Davide Gori and Paolo Manzoni
Vaccines 2024, 12(6), 640; https://doi.org/10.3390/vaccines12060640
Available online: https://www.mdpi.com/2076-393X/12/6/640

5. “Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV–ΔG–Spike Vaccine”
by Yfat Yahalom-Ronen, Sharon Melamed, Boaz Politi, Noam Erez, Hadas Tamir, Liat Bar-On, Julia Ryvkin, Dena Leshkowitz, Ofir Israeli, Shay Weiss et al.
Vaccines 2024, 12(5), 491; https://doi.org/10.3390/vaccines12050491
Available online: https://www.mdpi.com/2076-393X/12/5/491

6. “Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination”
by Jimmie L. Bullock, Jr., Thomas E. Hickey, Troy J. Kemp, Jordan Metz, Sarah Loftus, Katarzyna Haynesworth, Nicholas Castro, Brian T. Luke, Douglas R. Lowy and Ligia A. Pinto
Vaccines 2024, 12(5), 516; https://doi.org/10.3390/vaccines12050516
Available online: https://www.mdpi.com/2076-393X/12/5/516

7. “Integrating Digital Health Solutions with Immunization Strategies: Improving Immunization Coverage and Monitoring in the Post-COVID-19 Era”
by Grazia Pavia, Francesco Branda, Alessandra Ciccozzi, Chiara Romano, Chiara Locci, Ilenia Azzena, Noemi Pascale, Nadia Marascio, Angela Quirino, Giovanni Matera et al.
Vaccines 2024, 12(8), 847; https://doi.org/10.3390/vaccines12080847
Available online: https://www.mdpi.com/2076-393X/12/8/847

8. “Intranasally inoculated SARS-CoV-2 spike protein combined with mucoadhesive polymer induces broad and long-lasting immunity”
by Tomoko Honda, Sakiko Toyama, Yusuke Matsumoto, Takahiro Sanada, Fumihiko Yasui, Aya Koseki, Risa Kono, Naoki Yamamoto, Takashi Kamishita, Natsumi Kodake et al.
Vaccines 2024, 12(7), 794; https://doi.org/10.3390/vaccines12070794
Available online: https://www.mdpi.com/2076-393X/12/7/794

9. “COVID-19 Booster Vaccination Status and Long COVID in the United States: A Nationally Representative Cross-Sectional Study”
by Jamie L. Romeiser and  Kelsey Schoeneck
Vaccines 2024, 12(6), 688; https://doi.org/10.3390/vaccines12060688
Available online: https://www.mdpi.com/2076-393X/12/6/688

10. “Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice”
by Anders Frische, Karen Angeliki Krogfelt, Anders Fomsgaard and Ria Lassaunière
Vaccines 2024, 12(3), 218; https://doi.org/10.3390/vaccines12030218
Available online: https://www.mdpi.com/2076-393X/12/3/218

MDPI, a pioneer in scholarly open access publishing, and the Lee Kong Chian School of Medicine (LKCMedicine), Singapore, proudly announce the successful conclusion of the first edition the MDPI Early Career Researcher Awards. The awards, which recognize outstanding contributions to medical and biomedical research, were presented to six exceptional researchers during an awards ceremony held at LKCMedicine HQ Building on 28 November 2024.

Honoring Excellence in Research

The awards recognize exceptional postdoctoral researchers and Ph.D. students who have demonstrated outstanding originality, innovation, and impact in their respective fields. We are honored to announce the winners of the 2024 edition:

Early Career Researcher (Postdoc) Award:

• Dr. Theresia Handayani Mina, “Adiposity and Metabolic Health in Asian Populations: An Epidemiological Study Using Dual-Energy X-Ray Absorptiometry in Singapore”;
• Dr. Erfan Rezvani Ghomi, “Wound Healing Improvement by Novel Aligned Antimicrobial Nanofibrous 3D Scaffolds”;
• Dr. Yadollah Ranjbar Slamloo, “Functional Alterations of The Prefrontal Circuit Underlying Cognitive Aging in Mice”.

Early Career Researcher (Ph.D.) Award:

• Pritisha Rozario, “Mechanistic Basis for Potassium Efflux-Driven Activation of the Human NLRP1 Inflammasome”;

• Michelle Law Cheok Yien, “Chikungunya Virus Nonstructural Protein 1 is a Versatile RNA Capping and Decapping Enzyme”;
• Yin Ruoyu, “The Use of Digital Mental Health and Wellbeing Tools in Older Adults: A Mixed Method Study”.

Our collaboration highlights a shared commitment to recognizing exceptional talent and research within the academic community, addressing today’s healthcare challenges, and inspiring continued innovation.

Looking Ahead to 2025

Building on the success of the first edition, MDPI and LKCMedicine are excited to announce that the 2025 MDPI Early Researcher Awards will continue to celebrate excellence and innovation in medical research. The next edition promises to expand its scope, introducing new categories and providing even greater recognition for impactful research.

Further details on the 2025 awards, including nomination criteria and timelines, will be shared in the coming months. We remain committed to fostering a culture of research excellence and collaboration within the global scientific community.